Moreover, PPARγ agonists attenuated oxidative stress and the behavioral autism-like features in rats treated with valproic or propionic acid, which induce autism-like symptoms, including social impairment, repetitive behavior, hyperactivity, anxiety, and low exploratory activity [103,104]. Here, PPARG is linked to autism.